Mental & Neurological

My OCD journey 2: learning and compassion in tough times

In this blog, Karen Morley, who in 2018 wrote for Evidently Cochrane about her experiences of OCD (obsessive compulsive disorder) and how evidence helped her, tells us what has happened since, including the impact of the COVID-19 pandemic on her mental health, the challenges, and things she has found empowering.

Epilepsy: what are the best medications?

In this blog for people making choices about epilepsy medication, Dr Alexandre Mathy, a neurology registrar at Oxford University Hospitals, explains what the latest Cochrane evidence tells us about which medications may be most effective and best tolerated for people with focal seizures or generalised onset tonic‐clonic seizures. 

Preventing dementia: what’s the evidence?

In a blog for non-medical people, James Garrard, Specialist Registrar in Geriatric Medicine, looks at the evidence of drug and non-drug approaches to try and prevent dementia.

Commonly-prescribed drugs and dementia: should we be worried?

In this blog for people interested in memory, thinking problems and dementia, Jodi Watt (a Researcher at the University of Glasgow) looks at the latest Cochrane evidence on whether a class of commonly-used medications (anticholinergics) might increase people’s risk of future memory problems, or even dementia.

Tube feeding for people with severe dementia: making decisions

Charlotte Squires, a trainee doctor in older adult care, reflects on issues with eating for people with severe dementia and options for supporting them, including the latest evidence on tube feeding. Sarah Chapman and friend Sue share experience from supporting their mums with dementia.

Predicting depression relapse: is this possible and useful?

In this blog for clinicians, researchers, people with depression and those supporting them, Andrew Moriarty (Academic GP), Nick Meader (Researcher), Emma Williams (Expert by experience) and Carolyn Chew-Graham (Professor of General Practice Research) look at the latest Cochrane evidence on predicting relapse of depression. Is predicting relapse possible, and likely to be useful to general practitioners (GPs) and patients?

Stopping antidepressants: what is the best way to come off them?

In this blog for patients and doctors, Dr Mark Horowitz, training psychiatrist and Clinical Research Fellow at University College London, looks at the latest Cochrane evidence on how to safely stop antidepressants and explores the implications for patients and doctors having to navigate this area so neglected by medical researchers. Mark’s personal experience of the difficulty in coming off antidepressants led to an interest in the little-understood field of stopping psychiatric medication, and the balance of harms and benefits.

Behavioural Activation Therapy for depression: what’s the evidence?

In this blog for people with depression and their mental health practitioners, Emily Sanger, a Junior Doctor in York, looks at the latest Cochrane evidence from two reviews on Behavioural Activation Therapy and explores how well it works for depression in adults, with and without long-term physical conditions.